Definium Therapeutics Inc. Common Shares vs GlobalFoundries Inc. Ordinary Shares — how do they compare? Definium Therapeutics Inc. Common Shares trades at $37 (market cap $4.59B), while GlobalFoundries Inc. Ordinary Shares trades at $47.73 (market cap $27.51B). The key difference: GlobalFoundries Inc. Ordinary Shares is far larger — about 6× Definium Therapeutics Inc. Common Shares's market cap, and GlobalFoundries Inc. Ordinary Shares pays a 0.97% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and GlobalFoundries Inc. Ordinary Shares for 0 Days on average.
| DFTX | GFS | |
|---|---|---|
Market Cap | $4.59B | $27.51B |
Volume | 2,103,937 | 10,416,572 |
Sector | Health | Technology |
52-Week High | $48.45 | $89.96 |
52-Week Low | $10.68 | $32.24 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.55B | $26.80B |
Dividend Yield | — | 0.97% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →GlobalFoundries is a semiconductor foundry that manufactures chips for other companies. Its technologies serve automotive, communications, industrial, and consumer markets.
Read more on GFS →